Life Sciences
Asia-Pacific Guide 2025 : Asia-Pacific Region
Band 2
Contact number
+852 2585 0888Chambers Review
Thanks to its global network, Morrison Foerster is well placed to provide IP and corporate support to biotech companies and leading investors on joint ventures, funding, patent litigation and enforcement, and licensing issues in the life sciences sphere. It is also noted for core technology expertise within the sector and an impressive transactional capability across the Asia-Pacific region. The firm is particularly well versed in negotiating the licensing and development of pharmaceutical products as part of joint venture arrangements. The team regularly coordinates venture capital and corporate transactions with a network of colleagues based in offices across the USA.
Gordon Milner in Hong Kong and Sun Chuan in Shanghai, are key contacts for the China life sciences practice.The key contact for the firm's life sciences practice in Japan is Gary Smith.
Work Highlights
- Morrison Foerster's Tokyo and US offices advised Astellas Pharma in its USD175 million acquisition of Propella Therapeutics, a biopharmaceutical company that combined medicinal chemistry with lymphatic targeting to create new oncology drugs.
Strengths
Provided by Chambers
"MoFo explained complex legal issues in a concise and easily understandable manner."
"Morrison Foerster has solid knowledge and experience in life sciences and can provide valued know-how to facilitate such kinds of transactions for clients."
"MoFo explained complex legal issues in a concise and easily understandable manner."
"Morrison Foerster has solid knowledge and experience in life sciences and can provide valued know-how to facilitate such kinds of transactions for clients."